Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 212

    1.

    Urinary properdin excretion is associated with intrarenal complement activation and poor renal function.

    Siezenga MA, van der Geest RN, Mallat MJ, Rabelink TJ, Daha MR, Berger SP.

    Nephrol Dial Transplant. 2009 Nov 23. [Epub ahead of print]PMID: 19934084 [PubMed - as supplied by publisher]Related articles

    2.

    Increased Carotid Intima Media Thickness as a Predictor of the Presence and Extent of Abnormal Myocardial Perfusion in Type 2 Diabetes Mellitus.

    Djaberi R, Schuijf JD, Jukema JW, Rabelink TJ, Stokkel MP, Smit JW, de Koning EJ, Bax JJ.

    Diabetes Care. 2009 Nov 16. [Epub ahead of print]PMID: 19918012 [PubMed - as supplied by publisher]Related articles

    3.

    Endothelial dysfunction in diabetic patients with abnormal myocardial perfusion in the absence of epicardial obstructive coronary artery disease.

    Djaberi R, Roodt J, Schuijf JD, Rabelink TJ, de Koning EJ, Pereira AM, Stokkel MP, Smit JW, Bax JJ, Jukema JW.

    J Nucl Med. 2009 Dec;50(12):1980-6. Epub 2009 Nov 12.PMID: 19910438 [PubMed - in process]Related articles

    4.

    Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.

    Reinders ME, Fibbe WE, Rabelink TJ.

    Nephrol Dial Transplant. 2009 Oct 26. [Epub ahead of print]PMID: 19861311 [PubMed - as supplied by publisher]Related articles

    5.

    Reversibility of capillary density after discontinuation of bevacizumab treatment.

    Steeghs N, Rabelink TJ, Op 't Roodt J, Batman E, Cluitmans FH, Weijl NI, de Koning E, Gelderblom H.

    Ann Oncol. 2009 Oct 23. [Epub ahead of print]PMID: 19854721 [PubMed - as supplied by publisher]Related articles

    6.

    Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery disease.

    Djaberi R, Schuijf JD, de Koning EJ, Rabelink TJ, Smit JW, Kroft LJ, Pereira AM, Scholte AJ, Spaans M, Romijn JA, de Roos A, van der Wall EE, Jukema JW, Bax JJ.

    Am J Cardiol. 2009 Oct 15;104(8):1041-6.PMID: 19801021 [PubMed - indexed for MEDLINE]Related articles

    7.

    Salt is getting under our skin.

    Rabelink TJ, Rotmans JI.

    Nephrol Dial Transplant. 2009 Nov;24(11):3282-3. Epub 2009 Aug 12. No abstract available. PMID: 19675060 [PubMed - in process]Related articles

    8.

    Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians.

    Siezenga MA, Chandie Shaw PK, van der Geest RN, Mollnes TE, Daha MR, Rabelink TJ, Berger SP.

    Clin Exp Immunol. 2009 Jul;157(1):98-103.PMID: 19659775 [PubMed - indexed for MEDLINE]Related articles

    9.

    Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese.

    Mooyaart AL, van Valkengoed IG, Shaw PK, Peters V, Baelde HJ, Rabelink TJ, Bruijn JA, Stronks K, de Heer E.

    Diabetes Res Clin Pract. 2009 Sep;85(3):272-8. Epub 2009 Jul 3.PMID: 19577318 [PubMed - in process]Related articles

    10.

    The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.

    de Bie MK, van Dam B, Gaasbeek A, van Buren M, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.

    Eur Heart J. 2009 Jul;30(13):1559-64. Epub 2009 May 22. Review.PMID: 19465437 [PubMed - indexed for MEDLINE]Related articles

    11.

    Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

    Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ.

    Ann Intern Med. 2009 Jun 16;150(12):840-8, W150-1. Epub 2009 May 4.PMID: 19414832 [PubMed - indexed for MEDLINE]Related articles

    12.

    Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia.

    Loomans CJ, van Haperen R, Duijs JM, Verseyden C, de Crom R, Leenen PJ, Drexhage HA, de Boer HC, de Koning EJ, Rabelink TJ, Staal FJ, van Zonneveld AJ.

    Mol Med. 2009 May-Jun;15(5-6):152-9. Epub 2009 Mar 11.PMID: 19295918 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

    van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax PH, Rabelink TJ, van Zonneveld AJ.

    J Cell Mol Med. 2009 Aug;13(8A):1577-85.PMID: 19120690 [PubMed - in process]Related articles

    14.

    Complement activation by tubular cells is mediated by properdin binding.

    Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, Berger SP.

    Am J Physiol Renal Physiol. 2008 Nov;295(5):F1397-403. Epub 2008 Aug 27.PMID: 18753294 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Nifedipine improves endothelial function: role of endothelial progenitor cells.

    Sugiura T, Kondo T, Kureishi-Bando Y, Numaguchi Y, Yoshida O, Dohi Y, Kimura G, Ueda R, Rabelink TJ, Murohara T.

    Hypertension. 2008 Sep;52(3):491-8. Epub 2008 Jul 21.PMID: 18645050 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus.

    Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, Huisman MV, Jukema JW.

    Diabetologia. 2008 Sep;51(9):1581-93. Epub 2008 Jul 8. Review.PMID: 18607561 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.

    de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.

    Curr Med Res Opin. 2008 Aug;24(8):2151-7. Epub 2008 Jun 17.PMID: 18561878 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.

    Steeghs N, Gelderblom H, Roodt JO, Christensen O, Rajagopalan P, Hovens M, Putter H, Rabelink TJ, de Koning E.

    Clin Cancer Res. 2008 Jun 1;14(11):3470-6.PMID: 18519779 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency.

    van der Klaauw AA, Pereira AM, Rabelink TJ, Corssmit EP, Zonneveld AJ, Pijl H, de Boer HC, Smit JW, Romijn JA, de Koning EJ.

    Eur J Endocrinol. 2008 Aug;159(2):105-11. Epub 2008 May 21.PMID: 18495694 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted anti-atherosclerotic therapy.

    Westerweel PE, Rabelink TJ, Rookmaaker MB, Gröne HJ, Verhaar MC.

    Thromb Haemost. 2008 Apr;99(4):794-5. No abstract available. PMID: 18392345 [PubMed - indexed for MEDLINE]Related articles

    21.

    Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus.

    Nieuwdorp M, Vergeer M, Bisoendial RJ, op 't Roodt J, Levels H, Birjmohun RS, Kuivenhoven JA, Basser R, Rabelink TJ, Kastelein JJ, Stroes ES.

    Diabetologia. 2008 Jun;51(6):1081-4. Epub 2008 Apr 4. No abstract available. PMID: 18389214 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Preservation of beta-cell function by targeting beta-cell mass.

    de Koning EJ, Bonner-Weir S, Rabelink TJ.

    Trends Pharmacol Sci. 2008 Apr;29(4):218-27. Epub 2008 Mar 21. Review.PMID: 18359095 [PubMed - indexed for MEDLINE]Related articles

    23.

    Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity.

    Alizadeh Dehnavi R, de Roos A, Rabelink TJ, van Pelt J, Wensink MJ, Romijn JA, Tamsma JT.

    Atherosclerosis. 2008 Oct;200(2):417-23. Epub 2008 Mar 4.PMID: 18289549 [PubMed - indexed for MEDLINE]Related articles

    24.

    Erythropoietin, progenitors, and repair.

    Aydin Z, Duijs J, Bajema IM, van Zonneveld AJ, Rabelink TJ.

    Kidney Int Suppl. 2007 Nov;(107):S16-20. Review.PMID: 17943139 [PubMed - indexed for MEDLINE]Related articles

    25.

    Opportunities and challenges for mesenchymal stem cell-mediated heart repair.

    Atsma DE, Fibbe WE, Rabelink TJ.

    Curr Opin Lipidol. 2007 Dec;18(6):645-9. Review.PMID: 17993810 [PubMed - indexed for MEDLINE]Related articles

    26.

    Peritubular endothelium: the Achilles heel of the kidney?

    Rabelink TJ, Wijewickrama DC, de Koning EJ.

    Kidney Int. 2007 Oct;72(8):926-30. Epub 2007 Jul 4. Review.PMID: 17609688 [PubMed - indexed for MEDLINE]Related articles

    27.

    Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo.

    Rookmaaker MB, Verhaar MC, de Boer HC, Goldschmeding R, Joles JA, Koomans HA, Gröne HJ, Rabelink TJ.

    Am J Physiol Renal Physiol. 2007 Aug;293(2):F624-30. Epub 2007 Jun 13.PMID: 17567937 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects.

    Chandie Shaw PK, Berger SP, Mallat M, Frölich M, Dekker FW, Rabelink TJ.

    Diabetes Care. 2007 Jul;30(7):1840-4. Epub 2007 Apr 24.PMID: 17456841 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Endothelial function and dysfunction: testing and clinical relevance.

    Deanfield JE, Halcox JP, Rabelink TJ.

    Circulation. 2007 Mar 13;115(10):1285-95. Review. No abstract available. PMID: 17353456 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

    Baelde HJ, Eikmans M, Lappin DW, Doran PP, Hohenadel D, Brinkkoetter PT, van der Woude FJ, Waldherr R, Rabelink TJ, de Heer E, Bruijn JA.

    Kidney Int. 2007 Apr;71(7):637-45. Epub 2007 Jan 31.PMID: 17264876 [PubMed - indexed for MEDLINE]Related articles

    31.

    Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.

    Willemsen JM, Westerink JW, Dallinga-Thie GM, van Zonneveld AJ, Gaillard CA, Rabelink TJ, de Koning EJ.

    J Cardiovasc Pharmacol. 2007 Jan;49(1):6-12.PMID: 17261957 [PubMed - indexed for MEDLINE]Related articles

    32.

    New horizons in prevention and treatment of ischaemic injury to kidney transplants.

    Aydin Z, van Zonneveld AJ, de Fijter JW, Rabelink TJ.

    Nephrol Dial Transplant. 2007 Feb;22(2):342-6. Epub 2006 Nov 28. Review. No abstract available. PMID: 17132706 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Coupling eNOS uncoupling to the innate immune response.

    Rabelink TJ, van Zonneveld AJ.

    Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2585-7. No abstract available. PMID: 17110608 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.

    Coll B, van Wijk JP, Parra S, Castro Cabezas M, Hoepelman IM, Alonso-Villaverde C, de Koning EJ, Camps J, Ferre N, Rabelink TJ, Tous M, Joven J.

    Eur J Pharmacol. 2006 Aug 21;544(1-3):104-10. Epub 2006 Jun 16.PMID: 16843455 [PubMed - indexed for MEDLINE]Related articles

    35.

    Stem cell therapy for glomerular disease.

    Rabelink TJ, van Kooten C.

    J Am Soc Nephrol. 2006 Aug;17(8):2086-8. Epub 2006 Jul 12. No abstract available. PMID: 16837640 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.

    Martens FM, Rabelink TJ, op 't Roodt J, de Koning EJ, Visseren FL.

    Eur Heart J. 2006 Jul;27(13):1605-9. Epub 2006 Jun 8.PMID: 16762982 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.

    Goettsch WG, Heintjes EM, Kastelein JJ, Rabelink TJ, Johansson S, Herings RM.

    Pharmacoepidemiol Drug Saf. 2006 Jul;15(7):435-43.PMID: 16761304 [PubMed - indexed for MEDLINE]Related articles

    38.

    South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients.

    Chandie Shaw PK, Baboe F, van Es LA, van der Vijver JC, van de Ree MA, de Jonge N, Rabelink TJ.

    Diabetes Care. 2006 Jun;29(6):1383-5. No abstract available. PMID: 16732026 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression.

    Loomans CJ, Wan H, de Crom R, van Haperen R, de Boer HC, Leenen PJ, Drexhage HA, Rabelink TJ, van Zonneveld AJ, Staal FJ.

    Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1760-7. Epub 2006 May 25.PMID: 16728651 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.

    de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, Rabelink TJ, van Zonneveld AJ.

    Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1653-9. Epub 2006 Apr 20.PMID: 16627804 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients.

    van Wijk JP, de Koning EJ, Cabezas MC, Joven J, op't Roodt J, Rabelink TJ, Hoepelman AM.

    J Am Coll Cardiol. 2006 Mar 21;47(6):1117-23. Epub 2006 Feb 23.PMID: 16545639 [PubMed - indexed for MEDLINE]Related articles

    42.

    Endothelial progenitor cells: biology and therapeutic potential in hypertension.

    van Zonneveld AJ, Rabelink TJ.

    Curr Opin Nephrol Hypertens. 2006 Mar;15(2):167-72. Review.PMID: 16481884 [PubMed - indexed for MEDLINE]Related articles

    43.

    Angiogenesis and endothelial cell repair in renal disease and allograft rejection.

    Reinders ME, Rabelink TJ, Briscoe DM.

    J Am Soc Nephrol. 2006 Apr;17(4):932-42. Epub 2006 Feb 15. Review.PMID: 16481411 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?

    Loomans CJ, De Koning EJ, Staal FJ, Rabelink TJ, Zonneveld AJ.

    Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1468-75. Review.PMID: 16356109 [PubMed - indexed for MEDLINE]Related articles

    45.

    Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase.

    Bevers LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, Koomans HA, Verhaar MC, Joles JA.

    Hypertension. 2006 Jan;47(1):87-94. Epub 2005 Dec 12.PMID: 16344367 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

    Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

    J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.PMID: 16306801 [PubMed - indexed for MEDLINE]Related articles

    47.

    Endothelial nitric oxide synthase: host defense enzyme of the endothelium?

    Rabelink TJ, Luscher TF.

    Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):267-71. Epub 2005 Nov 17. Review.PMID: 16293798 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    A study of neovascularization in the rat ischemic hindlimb using Araldite casting and Spalteholtz tissue clearing.

    Westerweel PE, Rookmaaker MB, van Zonneveld AJ, Bleys RL, Rabelink TJ, Verhaar MC.

    Cardiovasc Pathol. 2005 Nov-Dec;14(6):294-7.PMID: 16286037 [PubMed - indexed for MEDLINE]Related articles

    49.

    Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.

    van Wijk JP, de Koning EJ, Cabezas MC, op't Roodt J, Joven J, Rabelink TJ, Hoepelman AI.

    Ann Intern Med. 2005 Sep 6;143(5):337-46. Erratum in: Ann Intern Med. 2005 Nov 1;143(9):695. Dosage error in published abstract; MEDLINE/PubMed abstract corrected. PMID: 16144892 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes.

    van Wijk JP, Cabezas MC, Coll B, Joven J, Rabelink TJ, de Koning EJ.

    Atherosclerosis. 2006 May;186(1):152-9. Epub 2005 Aug 30.PMID: 16137694 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...